Navigation Links
Anti-Craving Drug, Naltrexone Helps Women Quit Smoking

A new study finds that the anti-craving drug, Naltrexone may lessen cessation-related weight gain and negative moods and women who are trying to quit smoking appear //to benefit more than men. As a first step towards individualized medicine, scientists are focusing on gender differences in nicotine addiction and in treatment.

Researchers Andrea King and her colleagues of the University of Chicago have added a drug called Naltrexone to traditional methods of quitting smoking like the nicotine patch and counseling. Naltrexone is believed to block the chemical signals that relay pleasure to the brain. The study randomly assigned 110 adult smokers to receive two months of Naltrexone (brand name Revia) or inactive placebo pills in combination with six months of behavioral counseling sessions and one month of the nicotine patch.

But Naltrexone seemed to help the women more than the men. 58% of female smokers taking the drug were able to quit, compared with only 39% of those taking placebos. In contrast, the quit rates in men taking Naltrexone or placebo were almost the same.

"Women seem to be more sensitive to Naltrexone in terms of its decrease in their negative mood symptoms during withdrawal," King says. "Naltrexone also significantly decreased their craving. With men, there was no difference. The nicotine patch for men seems to do the trick." Naltrexone also prevented the weight gain that commonly comes with giving up smoking.

Though Nicotine replacement patches and other smoking cessation medications help most women smokers, scientists are wondering why the nicotine patch is less effective in women than in men. A future study will look at the association between hormones and women’s success in quitting.

King said, “even though there is not a lot of statistical power behind the findings, still, the results do provide initial evidence of Naltrexone as a smoking cessation aid in women.”


SI
'"/>




Page: 1

Related medicine news :

1. FDA Approves New HIV Drug, Viread
2. FDA Approves New Arthritis Drug, Bextra
3. New Drug, Pleconaril speeds recovery from common cold
4. Herceptin Not A ‘Wonder’ Drug, Says The Lanct
5. NGO Files Pre-Grant Opposition Against Anti-HIV Drug, Combivir
6. Life-Saving Cancer Drug, Herceptin Will be Available Free for Breast Cancer Patients in Wales
7. Diabetes Drug, Exenatide, Good For Blood Sugar Levels and Weight Loss
8. FDA Gives Approval for Skin Cancer Drug, Zolinza
9. Was the Warning of a Severe Reaction To a Drug, Overlooked?
10. Teen Marijuana Use Does Not Predict Drug, Alcohol Abuse
11. Skip the Drug, Pick Up Your Shoes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... ... December 07, 2016 , ... A quote from Dr. Edward ... comments on social media that offer a rare glimpse into the mind of those ... and New York Times bestselling author, has described people with ADHD as having “Ferrari ...
(Date:12/7/2016)... Hollywood, Fl (PRWEB) , ... December 07, 2016 , ... When it came time to ... new heart. Just 40 minutes later, the Pediatric Heart Transplant team at Joe ... true making the Weston teen the hospital’s 30th heart transplant recipient. , “He was ...
(Date:12/7/2016)... ... 07, 2016 , ... Baciocco Brothers Insurance Agency, a northern ... Sacramento/Folsom region, is initiating a charity event to raise support and awareness for ... treatment center in Sacramento works to provide area teens and families with treatment ...
(Date:12/7/2016)... ... December 07, 2016 , ... AlignLife clinics nationwide are giving ... are not fortunate enough to receive bountiful gifts wrapped tightly under a Christmas Tree. ... to the children of the world. , In exchange for generous donations, customers will ...
(Date:12/7/2016)... ... 2016 , ... Sharon Kleyne, host of the nationally syndicated radio program, The ... of America, declared on her radio program in November 2016 the need to educate ... bullies attack leaders in corporate America, they are trying to take advantage of successful ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... , December 7, 2016 ... Market Research titled , Global Market Study on Multiplex Detection ... 2024 , the global multiplex detection immunoassay market is expected ... period 2016-2024. ... , , ...
(Date:12/7/2016)... FRANCISCO , December 7, 2016 ... expected to reach a value of USD 3.9 ... by Grand View Research, Inc. The growth of ... of donor and continuous technological advancements by the ... increasing continuously due to increasing donation, rising awareness ...
(Date:12/6/2016)... , Dec. 6, 2016  Alopexx Oncology, LLC announced ... recombinant antibody fusion protein (immunocytokine) composed of interleukin-2 and ... same target on B cells as Rituxan and maintains ... but is also involved in tumor targeting, engagement of ... effect. The results of the study (abstract #95954) were ...
Breaking Medicine Technology: